Watch for Patients Getting OTC Primatene Mist for Asthma

January 2019

Primatene Mist (epinephrine) will return to OTC shelves for relieving occasional symptoms of mild asthma in patients age 12 and up.

It was withdrawn in 2011 due to chlorofluorocarbon (CFC) propellant regulations, NOT safety issues. But many were happy to see it go.

Now Primatene Mist is back with an HFA propellant.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Insurance Work Through "Step-Therapy" Rejections Efficiently
Medication Errors Prevent Mix-Ups Between Lamotrigine and Labetalol
Asthma Watch for Patients Getting OTC Primatene Mist for Asthma
Antihypertensives Listen for Patients Worried About Cancer Risk With Blood Pressure Meds
Cholesterol Ensure Patients Get the Right Statin Add-On
Cholesterol Anticipate More Patients Getting Vascepa to Help Reduce Heart Events
Antibiotics Keep an Eye Out for the New Tetracycline Antibiotic Nuzyra
Oral Health Help Patients With Non-Opioid Options for Dental Pain
Antiarrhythmics Keep Patients Taking Amiodarone Safe
MRSA Don't Automatically Substitute Generic Mupirocin for Bactroban Nasal
Supplements Be Ready for Questions About Eye Supplements for Blue Light
Epinephrine Know How the New EpiPen Generic Compares to Other Epinephrine Auto-Injectors